Literature DB >> 18415062

[Cutaneous vasculitides. A diagnostic approach].

K Schäkel1, M Meurer.   

Abstract

Vasculitis is characterized by an inflammatory reaction of vessel walls with damage to the dependent tissues. Forms of vasculitis which frequently have skin changes include leukocytoclastic angiitis (LcV), Henoch-Schönlein purpura (HSP), cutaneous polyarteriitis nodosum (cPAN), erythema elevatum et diutinum (EED) and urticarial vasculitis (UV). In other forms of vasculitis, systemic manifestations predominate but there are a variety of skin changes. Kawasaki disease (MK), cryoglobulinemic vasculitis (kV), Wegener granulomatosis (WG), Churg-Strauss syndrome (CSS) and microscopic polyangitis (MPA) belong to this group. The causes of vasculitis are heterogeneous. Triggers include infections, drugs, collagen vascular diseases, autoimmune diseases and lymphoproliferative disorders. Idiopathic vasculitis, particularly LcV and EED, occur only once and have a self-limited course. The diagnostic work up depends on the clinical picture and includes inflammatory markers, circulating immune complexes, different types of cryoglobulins and anti-neutrophilic cytoplasmic antibodies, collagen vascular disease specific autoantibodies and additional hematological studies. Vasculitis can manifest in many organs and requires a thorough work up specifically in cases where WG, MPA, CSS and PAN are under consideration.

Entities:  

Mesh:

Year:  2008        PMID: 18415062     DOI: 10.1007/s00105-008-1546-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  38 in total

Review 1.  Drug-induced vasculitis.

Authors:  Marta Lucia Cuellar
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  [Cryoglobulinemic vasculitis].

Authors:  A Gause; P Lamprecht
Journal:  Internist (Berl)       Date:  2003-02       Impact factor: 0.743

Review 3.  [Primary systemic vasculitides: diagnostic pathways].

Authors:  B Hellmich; J Voswinkel; P M Aries; W L Gross
Journal:  Dtsch Med Wochenschr       Date:  2004-06-04       Impact factor: 0.628

4.  Immune complex pathophysiology.

Authors:  Urs E Nydegger
Journal:  Ann N Y Acad Sci       Date:  2007-08       Impact factor: 5.691

5.  [Rare types of vasculitis as markers of plasmocytoma].

Authors:  A Marini; R Fenk; H Plettenberg; T Ruzicka; R Haas; U R Hengge
Journal:  Hautarzt       Date:  2006-02       Impact factor: 0.751

6.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

7.  Childhood vasculitides in Turkey: a nationwide survey.

Authors:  Seza Ozen; Aysin Bakkaloglu; Ruhan Dusunsel; Oguz Soylemezoglu; Fatih Ozaltin; Hakan Poyrazoglu; Ozgur Kasapcopur; Ozan Ozkaya; Fatos Yalcinkaya; Ayse Balat; Nurdan Kural; Osman Donmez; Harika Alpay; Ali Anarat; Sevgi Mir; Ayfer Gur-Guven; Ferah Sonmez; Faysal Gok
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

Review 8.  Clinical classification of vasculitis.

Authors:  Cord Sunderkötter; Anca Sindrilaru
Journal:  Eur J Dermatol       Date:  2006 Mar-Apr       Impact factor: 3.328

9.  Acute hemorrhagic edema of infancy.

Authors:  Hakan M Poyrazoğlu; Hüseyin Per; Zübeyde Gündüz; Ruhan Düşünsel; Duran Arslan; Nazmi NarIn; Hakan Gümüş
Journal:  Pediatr Int       Date:  2003-12       Impact factor: 1.524

10.  Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis.

Authors:  M D Davis; M S Daoud; B Kirby; L E Gibson; R S Rogers
Journal:  J Am Acad Dermatol       Date:  1998-06       Impact factor: 11.527

View more
  2 in total

1.  [Erythema elevatum et diutinum].

Authors:  E Mühlenstädt; A Mokosch; B Homey; J Reifenberger
Journal:  Hautarzt       Date:  2011-04       Impact factor: 0.751

Review 2.  [Molecular diagnosis of collagen vascular diseases and vasculitides].

Authors:  K Hoffmann; M Hertl; C Sitaru
Journal:  Hautarzt       Date:  2016-01       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.